Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.1.1.29: glycerate dehydrogenase

This is an abbreviated version!
For detailed information about glycerate dehydrogenase, go to the full flat file.

Word Map on EC 1.1.1.29

Reaction

D-glycerate
+
NAD+
=
Hydroxypyruvate
+
NADH
+
H+

Synonyms

D-glycerate dehydrogenase, dehydrogenase, glycerate, GDH, glyoxalate reductase/hydroxypyruvate reductase, glyoxylate reductase, GR/HPR, GRHPR, HPR, HPR1, hydroxypyruvate dehydrogenase, hydroxypyruvate reductase, hydroxypyruvate reductase 1, NADH-dependent hydroxypyruvate reductase

ECTree

     1 Oxidoreductases
         1.1 Acting on the CH-OH group of donors
             1.1.1 With NAD+ or NADP+ as acceptor
                1.1.1.29 glycerate dehydrogenase

Disease

Disease on EC 1.1.1.29 - glycerate dehydrogenase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
glycerate dehydrogenase deficiency
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.
Hyperoxaluria
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Hyperoxaluria, Primary
Coenzyme specificity of mammalian liver D-glycerate dehydrogenase.
Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease.
Extraction of glyceric and glycolic acids from urine with tetrahydrofuran: utility in detection of primary hyperoxaluria.
Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2).
Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2.
Oral findings associated with primary hyperoxaluria type I.
Perspectives in the assessment and management of patients with primary hyperoxaluria type I.
Primary hyperoxaluria type 2: enzymology.
Infections
Enteropathogenic Escherichia coli Infection Inhibits Intestinal Ascorbic Acid Uptake via Dysregulation of Its Transporter Expression.
Metabolic Diseases
Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II.
Urolithiasis
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.